Bovine spongiform encephalopathy (BSE) is a prion-associated disease where the infectious agent is thought to be a host-encoded protein with a protease-resistant conformation (PrP Sc ). Here, data are presented on the solubilization of purified murine BSE material, using guanidine-HCl as a denaturing agent. This treatment led to loss of infectivity, which was partially recovered on renaturation after dialysis to remove the chaotropic agent. The renatured product was then fractionated on an isopycnic sucrose-density gradient and the fractions were analysed for the presence of PrP Sc , nucleic acids and infectivity. It was found that the major part of PrP Sc ( 90 %) and the endogenous nucleic acids did not contribute towards the formation of infectious particles on renaturation. Infectivity was distributed in the top three, low-density fractions. Among these, the presence of considerable infectivity in the fraction of lowest density, with barely detectable PrP Sc , is of particular interest.
Introduction
Scrapie, Creutzfeldt-Jakob disease (CJD) and bovine spongiform encephalopathy (BSE) are slow, progressive neurological disorders belonging to the group of transmissible spongiform encephalopathies (TSEs) that are caused by infectious entities termed prions. These diseases lead to the lethal decline of cognitive and motor functions. As early as 1966, Alper and colleagues had suggested, from the anomalous resistance of scrapie agent to ionizing irradiation, that its size was too small for a viral genome and that it behaved more like a protein of the order of 100 kDa (Alper et al., 1966) . In 1982 , Prusiner (1982 proposed that the scrapie agent was not a virus but a proteinaceous infectious agent, which he called a ' prion', thus starting a worldwide controversy. In the years that followed, detection of nucleic acids in highly purified prion preparations prompted scientists to undertake direct and quantitative nucleic acid analysis on the size and number of nucleic acid molecules present. One study demonstrated that Author for correspondence : Theodoros Sklaviadis.
Fax j3 031 997645. e-mail sklaviadis !auth.gr nucleic acids of virus origin with significant molecular mass copurified with infectivity (Akowitz et al., 1994) , whereas another study claimed that only nucleic acids smaller than 80 nucleotides (Kellings et al., 1992) could be part of the infectious agent and, therefore, the infectious agent could not be a virus. In the meantime, the prion hypothesis, claiming that a protein was the predominant component of the agent, was supported by the formulation of the ' protein-only' hypothesis, which stated that the prion protein alone represents the infectious agent. According to this model, either the cellular prion (PrP C ) molecules spontaneously underwent transition under certain conditions or these were transformed into the pathogenic isoform by a catalytic reaction triggered by the latter, leading to the propagation of the pathogen itself.
It has been shown that denaturation of PrP Sc aggregates in vitro leads to the final loss of infectivity (Manuelidis et al., 1995 ; Riesner et al., 1996) . The same does not necessarily apply in the case of a report by Safar et al. (1993) , where conformational transitions did not affect infectivity. However, a model for the transformation of PrP C into infectious PrP Sc aggregates would be the ultimate proof of prion propagation. Several approaches have been reported in the literature, but so far none has achieved such a transformation conclusively with T. Manousis and others T. Manousis and others Fig. 1 . Western blot analysis of the murine BSE fraction p215-MN. Lanes : 1, gold staining for total protein ; 2, PrP-specific staining with the polyclonal rabbit antibody 78295 ; 3, PrP-specific staining following treatment with proteinase K. Each lane contains 100 mg brain tissue equivalent.
measurable infectivity (Gasset et al., 1993 ; Kocisko et al., 1994 ; Kaneko et al., 1995 ; Riesner et al., 1996) . Moreover, qualitative and conformational studies of the infectious material are complicated by the limited solubility of prions. So far, attempts to solubilize scrapie infectivity have not been successful (Prusiner et al., 1980 ; Millson & Manning, 1979) . Interestingly, the very property of insolubility of the TSE infectious agents is now used for the enrichment of infectivity, together with the introduction of proteinase K digestion in the purification protocols, thus giving rise to the PrP27-30 fraction . Even though this fraction is infectious, its infectivity when separated on SDS-PAGE (Brown et al., 1990) has not been confirmed .
Attempts to renature scrapie infectivity from guanidine (Gdn)-thiocyanide-or urea-treated samples were unsuccessful . There is considerable loss of infectivity ( 99n5 %) in the soluble fraction of hamster CJD infectious agent upon denaturation with 2n5 M Gdn-HCl (Manuelidis et al., 1995) . It has also been reported that, on renaturation, PrP Sc from the 263K strain of hamster scrapie that had been treated with 3 M Gdn-HCl regained resistance to proteinase K (Kocisko et al., 1994 ; Kaneko et al., 1995) ; however, as shown by subsequent investigators, this may not be the only factor governing infectivity (Hill et al., 1999) .
In the light of these findings, we have looked at the possibility of reconstructing the mouse-passaged BSE infectious agent after denaturation with Gdn-HCl and investigated the properties of the newly acquired product, including infectivity.
Methods
Purification of the infectious material. Brain tissue from BSEinfected mice was obtained frozen from the Central Veterinary Laboratory (Weybridge, UK). The procedures used for partial purification of the prion infectious agent have been described previously in detail (Sklaviadis et al., 1989) . In brief, frozen material was homogenized (10 % w\v in 25 mM Tris-HCl, pH 7n6, 10 % Sarkosyl and 5 mM PMSF) and spun at 25 000 g for 20 min at 20 mC. The supernatant was centrifuged again at 215 000 g for 2 h at 20 mC. The pellet, p215, was washed for 2 h at room temperature in 25 mM Tris-HCl, pH 7n6, containing 0n05 % Sarkosyl and then treated with 50 U micrococcal nuclease (MN) per g tissue equivalent in 20 mM Tris-HCl, pH 8n0, 4 mM CaCl # for 24 h at 37 mC under mild agitation in order to digest all accessible endogenous nucleotides. Another aliquot of MN was added, followed by further incubation for 1 h, and the reaction was terminated by the addition of a final concentration of 5 mM EGTA. After centrifugation at 13 000 g for 30 min, the pellet was washed twice with 25 mM Tris-HCl, pH 7n6. The washed pellet was designated as p215-MN. For digestion with proteinase K, 0n5 g brain equivalent of p215-MN was resuspended in 25 mM Tris-HCl, pH 7n6, and treated with 5 µg\ml proteinase K for 1 h at 37 mC with mild agitation. The digestion was terminated by adding a cocktail of 1 mM PMSF, 1 µM pepstatin, 1 µg\ml aprotinin and 1 µg\ml leupeptin (final concentrations) and spun at 13 000 g for 30 min. The pellet, designated as p215-PK, was washed and used for denaturation experiments. Unless stated, all experiments were done with p215-MN.
Denaturation, renaturation and isopycnic fractionation. For denaturation, 1 g wet tissue equivalent of p215-MN was resuspended in 340 µl of a solution containing 2n5 M Gdn-HCl in 25 mM Tris-HCl, pH 8n9, 0n05 % Sarkosyl and 0n5 mM PMSF and bath-sonicated five times (30 min each) with alternate vortexing (45 min each). The samples were then centrifuged at 13 000 g for 30 min. The pellet, designated as pG, was kept for further use, while the supernatant, sG, was dialysed exhaustively at room temperature against 25 mM Tris-HCl, pH 7n6, 1 mM PMSF and 0n05 % Sarkosyl in a Gibco BRL Microdialysis system with a membrane cut-off of 12-14 kDa. A linear, 30-86 % (w\v) sucrose gradient (3 ml) was poured over a cushion of 500 µl 86% (w\v) sucrose and the dialysed material (dsG) in 800 µl dialysis buffer, equivalent to 2 g tissue, was loaded on the sucrose gradient for isopycnic fractionation. Denaturation, dialysis and isopycnic fractionation took place at room temperature in the presence of 1 mM PMSF. The samples were spun at 220 000 g for 41 h at 25 mC. At the end of the run, eight fractions of 500 µl each were collected carefully from the gradient and kept frozen. Blank sucrose gradients were also run in order to estimate the density of sucrose in each fraction by refractive index measurements (Index Instruments).
All fractions, including those from the sucrose gradient, were divided into three aliquots for the estimation of PrP Sc , nucleic acid analysis and bioassays.
Estimation of PrP

Sc
. Proteins were separated on 13 % SDS-PAGE and blotted onto a PVDF membrane and stained with AuroDye Forte (Amersham Life Science) for the estimation of total protein. For PrP Scspecific staining, the membranes were blocked (1 h, room temperature) in 3 % BSA, 1 % Ficoll and 1 % polyvinyl pyrrolidone and incubated with a polyclonal anti-PrP primary antibody (78295 ; Kascsak et al., 1997) , a generous gift of R. Kascsak, diluted 1 : 5000 in the blocking solution, for 1 h at room temperature, washed three times for 10 min in 100 ml PBS, 0n1 % Tween and incubated further with a goat anti-rabbit secondary antibody conjugated with alkaline phosphatase (1 : 3000). NBT and BCIP were used as substrates to visualize the proteins. Quantification of PrP Sc on PVDF membranes (34-19 kDa bands) was performed by densitometry (ScanPack version 3.0, Biometra Biomedizinische Analytik). Proteins from the sucrose-density fractions were concentrated by precipitating with 10 vols ethanol before immunoblotting.
Analysis of nucleic acids. Nucleic acids were isolated from the second portion of each fraction. The procedure that was employed has been reported previously in detail (Sklaviadis et al., 1990 ; Akowitz et al., 1994) . In brief, nucleic acids were extracted with phenol-chloroform, Characterization of the murine BSE agent Characterization of the murine BSE agent Bioassays. The third portion from each fraction was suspended in normal saline and used for bioassays in 3-week-old IM (Sinc p( ) mice, in groups of 20 per fraction. Each mouse received the inoculum through two routes, 20 µl intra-cranially and 100 µl intra-peritoneally (Bruce et al., 1994) . Mice in the control group were inoculated intra-cranially with normal saline. Mice were scored from day 90 post-inoculation for early clinical and terminal signs of disease over a period of up to 400 days. Infectious units were calculated from mean incubation time for each group, based on a titration curve obtained from mice of the same genotype infected with the mouse BSE strain 301V (D. Taylor, Institute of Animal Health, Neuropathogenesis Unit, Edinburgh, UK, personal communication).
Results
Extraction of PrP
Sc -enriched material and dispersion of prion aggregates
High enrichment for PrP Sc was achieved in the p215 fraction. This was retained after treatment with MN in p215-MN, the major preparation used in this study (Fig. 1, lanes 1  and 2) .
Subsequent to its treatment with 2n5 M Gdn-HCl, a major part of p215-MN was collected as soluble supernatant (Manuelidis et al., 1995) , sG, while a very small portion remained in the form of a pellet, pG. Exhaustive dialysis of sG to remove Gdn-HCl generated dsG, which was then analysed on an isopycnic sucrose gradient for further characterization.
Composition of the sucrose gradient fractions
The sucrose-density gradient provided eight fractions, with densities ranging from 1n30 to 1n03 g\cm$. PrP Sc was found to be concentrated mainly in fractions 6, 7 and 8, with densities of 1n11, 1n09 and 1n03 g\cm$, respectively. Most of it moved into fractions 6 and 7 and only traces of the protein were seen in fraction 8 (Fig. 2 a, lanes 6-8) .
In contrast to the PrP Sc distribution, nucleic acids were found clustered in high-density fractions 1 and 2 and fractions 4, 5 and 6 (Fig. 2 b) . Small amounts were noticed in fraction 3 and fractions 7 and 8 were devoid of detectable nucleic acids. Nucleic acids were found associated with PrP Sc only in fraction 6 (Fig. 2 a, b ; lanes 6 ). Nucleic acids in the high-density rabbit antibody 78295. Each lane represents 2 g brain tissue equivalent. M, Molecular mass marker. Dots indicate PrP-specific bands that were used for densitometry analyses and comparison among the fractions. (b) Autoradiograph of 32 P-end-labelled nucleic acids that were isolated from the sucrose gradient fractions. φX174 HaeIII restriction fragments were used as markers. (c) Infectivity results presented as log 10 LD 50 titres per g brain tissue equivalent. Twenty mice of IM strain were included in each group. The value for each group was obtained from the mean incubation period (pSD ; Table 1) for that group and was based on a standard dose response curve for the 301V strain of mouse BSE in VM mice (same genotype as in IM mice used in this study), as determined by Spearman-Karber analysis.
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Table 1. Infectivity assay of fractions used in this study
The various inocula are indicated as : p215, precipitated infectious material ; p215-MN, MN-treated material ; sG, supernatant after Gdn-HCl treatment ; pG, pellet after Gdn-HCl treatment ; dsG, dialysed sG ; fr1-fr8, sucrose fractions 1-8 ; PK, proteinase K-treated p215-MN. fractions must be ' naked ', while those in fractions 4 and 5 are likely to be associated with other macromolecules in the form of protein-nucleic acid complexes.
Inoculum
Bioassays
Data on infectivity in the various fractions (Table 1) showed that p215 itself was highly infectious (5n8 log "! LD &! units), with no considerable loss of infectivity in the p215-MN fraction (5n4 log "! LD &! units). Following exposure of p215-MN to Gdn-HCl, the pG fraction exhibited low but measurable infectivity (1n9 log "! LD &! units), while the corresponding soluble sG fraction was not infectious. Partial infectivity (3n5 log "! LD &! units, two log units less than that of the predenatured material) was recovered in dsG, however, the dialysed supernatant.
Only fractions 6 (2n6 log "! LD &! units), 7 (2n8 log "! LD &! units) and 8 (2n3 log "! LD &! units) from the sucrose-density gradient were infectious (Tables 1 and 2, Fig. 2 c) . Infectivity that was detected in fraction 5 (Fig. 2 c) had to be from residual material from the fraction(s) above because, in addition to the negligible infectivity (0n8 log "! LD &! units) that this fraction showed, only six of 20 mice were infected, with an incubation period of 329p48 days, way beyond those presented by other infectious fractions. For these reasons, it was decided to not consider this fraction for further analysis. Comparison of the infectious fractions in terms of percentages (Table 2) showed that fraction 6, where nearly all of the nucleic acids were found, contained 0n6 % of the total PrP Sc and 31 % of the total infectivity. Fraction 7, with no detectable nucleic acids, PrP Sc (%)* 0n6 9 9 n2 0 n2 Nucleic acids (%) 100   Infectivity ( %) 31 52 17 * Percentages of PrP Sc were calculated by densitometry from bands marked with dots in Fig. 2 (a) , as explained in Methods. , Not detectable by the detection protocol applied (less than picogram quantities).
contained 99n2 % of PrP Sc and 52 % of total infectivity, while fraction 8, with no detectable nucleic acids and only 0n2% of PrP Sc , showed 17 % of infectivity. Obviously, the majority of the nucleic acids did not contribute towards infectivity, because both fractions 7 and 8 were infectious without detectable nucleic acids. The important observation is that fractions 6 and 8 were infective but had only meagre amounts of PrP Sc (0n6 and 0n2 %, respectively), thus making it clear that infectivity was not associated directly with abundance of PrP Sc . The absence of infectivity in fractions 1-4 precludes any crosscontamination among the fractions due to handling (Table 1) . These fractions also served as internal negative controls. As shown above, the analysis of dsG showed that, even though they were not linked to infectivity in the fractions, BGBI endogenous nucleic acids were definitely associated with renatured PrP Sc . This association was, however, found by using gel-retardation electrophoresis to be not specific (data not shown).
Discussion
The infectious nature of the pathogenic agent that causes prion diseases is still far from certain. In this study, an attempt has been made for the first time to define the properties of infectivity, in the mouse BSE agent. In order to achieve this, the infectious agent that was enriched in the form of the p215-MN fraction was denatured chaotropically under defined conditions in the presence of 2n5 M Gdn-HCl (Manuelidis et al., 1995 ; Kocisko et al., 1996) and renatured by gradual removal of the chaotropic agent. The renatured material was then checked for its properties in terms of composition and infectivity.
It was observed that, on treatment with 2n5 M Gdn-HCl, there was complete loss of infectivity in the supernatant, and only residual infectivity was detected in the pellet. These results are similar to those of Manuelidis et al. (1995) , where a loss of 99n5 % of the starting infectivity, under similar conditions, was reported with hamster CJD preparations. In other studies, where the 263K strain of hamster scrapie has been denatured with 2n5 M Gdn-HCl, partial disaggregation of PrP Sc has been noticed (Kocisko et al., 1996) and, in a more recent work (Caughey et al., 1997) , a 1000-fold reduction in infectivity has been observed without complete loss in the supernatant. None of the above workers, however, attempted to recover infectivity from the denatured preparations. Interestingly, in our hands, we have regained a portion of the infectivity after the removal of Gdn-HCl by dialysis (Fig. 2 c ; dsG). The differences between the above findings and those of our own study might be attributable to the different strains used in the studies. On the other hand, similarities that the results of this work present to those of Manuelidis et al. (1995) , where hamster CJD was used, may be explained by a common and an increased sensitivity of the two agents to chaotropic agents. The implications of such a similarity on the passing of the BSE agent to humans to cause variant CJD remains to be seen.
On further analysis with an isopycnic sucrose-density gradient, it was discovered that, in the renatured fraction, only a portion of the total PrP Sc was responsible for infectivity (Table 2) . It has been reported earlier that overexpression of PrP Sc was not a criterion for the onset of prion diseases in PrP +/− mice (Bueler et al., 1994) . It has also been shown that the BSE infectious agent can be transmitted to mice in the absence of detectable prion protein (Somerville & Dunn, 1996 ; Lasmezas et al., 1997) . Therefore, in accordance with the findings of other workers and using experiments in vitro, the present work confirms that, during infection, pathogenicity of the infectious agent (murine BSE in this study) is dependent on the correct conformation in vivo and not on the bulk of PrP Sc in the inoculum. A role of other macromolecules, not detected under the present conditions, as part of the infectious agent cannot be excluded. However, as shown by gold staining (Fig.  1, lane 1) , the relative purity of the starting preparation in terms of contamination with other proteins precludes such a possibility. In order to use a more defined starting material, we repeated our experiments with p215-MN after digestion with proteinase K (Fig. 1, lane 3) , but the preparation was not easily denatured with 2n5 M Gdn-HCl. Denaturation with 5 M Gdn-HCl to overcome this difficulty led to unrecoverable loss of infectivity (data not shown). It was also observed that only a part of the total infectivity in the starting material was recovered at the end of the denaturation-renaturation steps (Table 1 ). This could be due to only partial recovery of the correct conformation that may contribute structurally towards infectivity.
Although the nature of the prion itself is proteinaceous (Prusiner, 1982) , its ability to associate with nucleic acids (Akowitz et al., 1994) and also with RNA aptamers (Weiss et al., 1997) has been demonstrated earlier. Our own experiments have demonstrated the capability of PrP Sc -enriched preparations to bind nucleic acids in vitro (unpublished data). In this study, dsG was found to be associated with nucleic acids that were structurally protected, since dsG was derived from the p215-MN (micrococcal nuclease-treated) preparation. Even though their presence has been demonstrated for the first time in mouse BSE preparations, these endogenous nucleic acids did not seem to contribute towards infectivity and were bound non-specifically to the infectious complexes.
It is likely that novel states of the murine BSE agent were generated under the denaturing-renaturing conditions used in this study. Such unfolded\refolded stages of the agent may be extremely useful as templates for studying in vitro proteinprotein interactions of PrP Sc with its own cellular isoform or even other macromolecules from the same or different species, since these steps are known to precede\accompany transmission of prion diseases.
